Replies to post #34 on For Peanut and Milk Allergies (DBVT)

[Golden Cross]

DBV Technologies Announces Filing and Validation of Marketing Autho...
Montrouge, France, November 2, 2020DBV Technologies Announces Filing and Validation of Marketing Authorization Application for Viaskin™ Peanut by European Medicines Agency DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: $DBVT ), a clinical-stage bioph...
https://finance.yahoo.com/news/dbv-technologies-announces-filing-validation-063000296.html